The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III, open-label, randomized study of atezolizumab in combination with carboplatin + paclitaxel + bevacizumab compared with pemetrexed + cisplatin or carboplatin with stage IV non-squamous non-small cell lung cancer (NSCLC) with activating EGFR mutation or ALK translocation (ATLAS Trial).
 
Sehhoon Park
Stock and Other Ownership Interests - Lunit
 
Yun-Gyoo Lee
No Relationships to Disclose
 
Ji Hyun Park
No Relationships to Disclose
 
Gyeong-Won Lee
No Relationships to Disclose
 
Eun Joo Kang
No Relationships to Disclose
 
Yoon Ji Choi
No Relationships to Disclose
 
SeongHoon Shin
No Relationships to Disclose
 
Ji-Youn Han
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Takeda
Research Funding - Ono Pharmaceutical; Pfizer; Roche; Takeda
 
Suee Lee
No Relationships to Disclose
 
YuJung Kim
No Relationships to Disclose
 
Tae Min Kim
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Bayer; Boryung; Novartis; Sanofi; Takeda; Voronoi Health Analytics
 
Sang-We Kim
No Relationships to Disclose
 
Byoung Yong Shim
No Relationships to Disclose
 
Jinhyun Cho
No Relationships to Disclose
 
Hye Sook Kim
No Relationships to Disclose
 
Sang Gon Park
No Relationships to Disclose
 
Ki Hyeong Lee
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD
 
Ilhwan Kim
No Relationships to Disclose
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Lilly; MSD; TAKEDA
Consulting or Advisory Role - Alpha pharmaceutical; AstraZeneca; Boehringer Ingelheim; Lilly; MSD; TAKEDA